1. Significant frequency of cytotoxic T lymphocytes precursor cells specific for TNP-modified allogeneic cells in normal lymphocytes;Aizawa;Cell. Immun.,1986
2. Treatment of murine leukemia with spleen cells or sera from allogeneic mice immunized against the tumor;Alexander;Cancer Res.,1966
3. Characteristics of human natural killer cell clones: target specificity and phenotype;Allavena;J. Immun.,1984
4. Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug;Bonmassar,1970
5. Antigenic changes of L1210 leukemia in mice treated with 5-(3,3′-Dimethyl-1-Triazeno)-Imidazole-4-Carboxamide;Bonmassar;Cancer Res.,1972